Company / Inventory per Share
Apellis Pharmaceuticals, Inc. Inventory per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$1.15
FY2025
5-year range
$0.21 / $1.32
FY2021-FY2025
Trend
+68.2%
vs FY2024
Sector context
#36 of 105
Health Care
What the data says
At $1.15, Apellis Pharmaceuticals, Inc.'s inventory per share ranks #36 of 105 in the Health Care sector. Declined from $1.32 to $1.15 over the past 2 years.
Based on SEC 10-K filings.
1.15 in FY2025 with a 3-year CAGR of +9.2%.
Declined from $1.32 to $1.15 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#36 of 105 in Health CareTop 34% of 105This company $1.15 Sector average $30.82
▼
-96.3% below sector average
Key checks
Key Insights
- In FY2025, inventory per share increased 68.2% year-over-year.
- Ranks #36 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2023.
- Lowest inventory per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +68.2% |
| FY2024 | $0.68 | -48.5% |
| FY2023 | $1.32 | +50.3% |
| FY2022 | $0.88 | +310.8% |
| FY2021 | $0.21 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026